Location History:
- Montréal, CA (2011)
- Montreal, CA (2012 - 2013)
- St-Laurent, CA (2005 - 2024)
Company Filing History:
4 out of 5 
3 out of 29 
2 out of 3 Years Active: 2005-2024
Title: **The Innovative Journey of Serge Moffett**
Introduction
Serge Moffett, based in St-Laurent, Canada, has been a significant contributor to the field of biotechnology and immunology. With a remarkable portfolio of nine patents, Moffett's work focuses on developing advanced therapeutic tools, particularly in the area of vaccine development.
Latest Patents
Moffett's latest innovations include a series of patents on neoglycoconjugates serving as vaccines and therapeutic tools. These neoglycoconjugates are produced by conjugating a carbohydrate antigen intermediate to a free amine group of a carrier material, such as a carrier protein. The process involves a linker with specific functional groups that allow for the binding of carbohydrate antigens via various types of chemical bonds. This innovative method enhances the efficacy of vaccines and provides diagnostic solutions for cancers and viral infections, including those caused by SARS-CoV-2. The applications highlight the potential of neoglycoconjugates as vaccine candidates and therapeutic tools against diseases characterized by aberrant glycosylation.
Career Highlights
Throughout his career, Serge Moffett has made notable contributions while working at prominent companies such as Proscan Rx Pharma Inc. and Theratechnologies Inc. His experience in these organizations has not only refined his skills as an inventor but has also allowed him to translate scientific theories into practical applications.
Collaborations
Moffett has collaborated with esteemed professionals in his field, including Claudio A. Cuello and Uri H. Saragovi. These collaborations have played a crucial role in advancing his research and pushing the boundaries of current scientific understanding.
Conclusion
Serge Moffett represents the essence of innovation in biotechnology, with his work on neoglycoconjugates paving the way for potential breakthroughs in therapeutic applications and vaccine development. His contributions underscore the importance of collaboration and the relentless pursuit of knowledge in advancing medical science.